Clinical Trial Update: R-2487 in Patients With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

A Phase 1 study to evaluate R-2487 in patients with rheumatoid arthritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• R-2487

Snippet

Sponsor: Rise Therapeutics LLC | Conditions: Arthritis, Rheumatoid | Phase 1 | Status: RECRUITING